Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms

Figure 3 Receiver operating characteristic curves for biomarkers predicting stage IV lymphoma. A: Receiver operating characteristic curves for the systemic inflammation response index, programmed death-ligand 1/C-X-C motif chemokine receptor 3 (CXCR3), and programmed cell death protein 1/CXCR3; B: Receiver operating characteristic curves for CXCR3/monocyte subsets. SII: Systemic immune-inflammation index; SIRI: Systemic inflammation response index; PD-L1: Programmed death-ligand 1; CXCR3: C-X-C motif chemokine receptor 3; PD-1: Programmed cell death protein 1.